Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers.
Saved in:
| Title: | Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers. |
|---|---|
| Authors: | Watkins J; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Institute for Mathematical and Molecular Biomedicine, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom., Weekes D; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom., Shah V; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom., Gazinska P; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom., Joshi S; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom., Sidhu B; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom., Gillett C; Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom. King's Health Partners Cancer Biobank, King's College London, London, United Kingdom., Pinder S; Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom. King's Health Partners Cancer Biobank, King's College London, London, United Kingdom., Vanoli F; Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Jasin M; Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Mayrhofer M; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Isaksson A; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Cheang MC; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, Surrey, United Kingdom., Mirza H; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom., Frankum J; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom., Lord CJ; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom., Ashworth A; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom., Vinayak S; Department of Medicine, Stanford University School of Medicine, Stanford, California., Ford JM; Department of Medicine, Stanford University School of Medicine, Stanford, California., Telli ML; Department of Medicine, Stanford University School of Medicine, Stanford, California., Grigoriadis A; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom., Tutt AN; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom. The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom. andrew.tutt@kcl.ac.uk. |
| Source: | Cancer discovery [Cancer Discov] 2015 May; Vol. 5 (5), pp. 488-505. Date of Electronic Publication: 2015 Mar 13. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 25770156 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Watkins+J%22">Watkins J</searchLink>; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Institute for Mathematical and Molecular Biomedicine, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Weekes+D%22">Weekes D</searchLink>; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Shah+V%22">Shah V</searchLink>; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Gazinska+P%22">Gazinska P</searchLink>; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Joshi+S%22">Joshi S</searchLink>; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Sidhu+B%22">Sidhu B</searchLink>; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Gillett+C%22">Gillett C</searchLink>; Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom. King's Health Partners Cancer Biobank, King's College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Pinder+S%22">Pinder S</searchLink>; Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom. King's Health Partners Cancer Biobank, King's College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Vanoli+F%22">Vanoli F</searchLink>; Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Jasin+M%22">Jasin M</searchLink>; Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Mayrhofer+M%22">Mayrhofer M</searchLink>; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Isaksson+A%22">Isaksson A</searchLink>; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Cheang+MC%22">Cheang MC</searchLink>; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, Surrey, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Mirza+H%22">Mirza H</searchLink>; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Frankum+J%22">Frankum J</searchLink>; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lord+CJ%22">Lord CJ</searchLink>; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ashworth+A%22">Ashworth A</searchLink>; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Vinayak+S%22">Vinayak S</searchLink>; Department of Medicine, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Ford+JM%22">Ford JM</searchLink>; Department of Medicine, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Telli+ML%22">Telli ML</searchLink>; Department of Medicine, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Grigoriadis+A%22">Grigoriadis A</searchLink>; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Tutt+AN%22">Tutt AN</searchLink>; Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom. The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom. andrew.tutt@kcl.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101561693%22">Cancer discovery</searchLink> [Cancer Discov] 2015 May; Vol. 5 (5), pp. 488-505. <i>Date of Electronic Publication: </i>2015 Mar 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101561693 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2159-8290 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221598274%22">21598274 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Discov <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25770156 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/2159-8290.CD-14-1092 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 488 Titles: – TitleFull: Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Watkins J – PersonEntity: Name: NameFull: Weekes D – PersonEntity: Name: NameFull: Shah V – PersonEntity: Name: NameFull: Gazinska P – PersonEntity: Name: NameFull: Joshi S – PersonEntity: Name: NameFull: Sidhu B – PersonEntity: Name: NameFull: Gillett C – PersonEntity: Name: NameFull: Pinder S – PersonEntity: Name: NameFull: Vanoli F – PersonEntity: Name: NameFull: Jasin M – PersonEntity: Name: NameFull: Mayrhofer M – PersonEntity: Name: NameFull: Isaksson A – PersonEntity: Name: NameFull: Cheang MC – PersonEntity: Name: NameFull: Mirza H – PersonEntity: Name: NameFull: Frankum J – PersonEntity: Name: NameFull: Lord CJ – PersonEntity: Name: NameFull: Ashworth A – PersonEntity: Name: NameFull: Vinayak S – PersonEntity: Name: NameFull: Ford JM – PersonEntity: Name: NameFull: Telli ML – PersonEntity: Name: NameFull: Grigoriadis A – PersonEntity: Name: NameFull: Tutt AN IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2015 May Type: published Y: 2015 Identifiers: – Type: issn-electronic Value: 2159-8290 Numbering: – Type: volume Value: 5 – Type: issue Value: 5 Titles: – TitleFull: Cancer discovery Type: main |
| ResultId | 1 |
